Furthermore, TLR4 signaling has been linked to HCC invasion, multidrug resistance, tumor angiogenesis and metastases, and TLR4 antagonists suggested as therapeutic modalities for HCC (185–187). Here, TLR4 is linked to hepatocellular carcinoma.